Abstract

Under normal conditions, the most significant expansion and differentiation of the adult mammary gland occurs in response to systemic reproductive hormones during pregnancy and lactation to enable milk synthesis and secretion to sustain the offspring. However, human mammary tissue remodelling that takes place during pregnancy and lactation remains poorly understood due to the challenge of acquiring samples. We report here single-cell transcriptomic analysis of 110,744 viable breast cells isolated from human milk or non-lactating breast tissue, isolated from nine and seven donors, respectively. We found that human milk largely contains epithelial cells belonging to the luminal lineage and a repertoire of immune cells. Further transcriptomic analysis of the milk cells identified two distinct secretory cell types that shared similarities with luminal progenitors, but no populations comparable to hormone-responsive cells. Taken together, our data offers a reference map and a window into the cellular dynamics that occur during human lactation and may provide further insights on the interplay between pregnancy, lactation and breast cancer.

Human mammary tissue remodelling that takes place during pregnancy and lactation remains poorly understood. Here the authors characterize cells in human milk, identifying epithelial cells resembling luminal progenitors and immune cells, contributing insights into this process.

Details

Title
Transcriptional changes in the mammary gland during lactation revealed by single cell sequencing of cells from human milk
Author
Alecia-Jane, Twigger 1   VIAFID ORCID Logo  ; Engelbrecht, Lisa K 2 ; Bach, Karsten 3 ; Schultz-Pernice, Isabel 2   VIAFID ORCID Logo  ; Pensa, Sara 3 ; Stenning, Jack 3 ; Petricca Stefania 4 ; Scheel, Christina H 5 ; Khaled, Walid T 3   VIAFID ORCID Logo 

 University of Cambridge, Department of Pharmacology, Cambridge, England (GRID:grid.5335.0) (ISNI:0000000121885934); Wellcome-MRC Cambridge Stem Cell Institute, Cambridge, England (GRID:grid.449973.4) (ISNI:0000 0004 0612 0791); Helmholtz Zentrum München, Institute of Stem Cell Research, Munich, Germany (GRID:grid.4567.0) (ISNI:0000 0004 0483 2525) 
 Helmholtz Zentrum München, Institute of Stem Cell Research, Munich, Germany (GRID:grid.4567.0) (ISNI:0000 0004 0483 2525) 
 University of Cambridge, Department of Pharmacology, Cambridge, England (GRID:grid.5335.0) (ISNI:0000000121885934); Wellcome-MRC Cambridge Stem Cell Institute, Cambridge, England (GRID:grid.449973.4) (ISNI:0000 0004 0612 0791) 
 Helmholtz Zentrum München, Institute of Stem Cell Research, Munich, Germany (GRID:grid.4567.0) (ISNI:0000 0004 0483 2525); LMU Munich, Biomedical Center (BMC), Division of Physiological Genomics, Faculty of Medicine, Munich, Germany (GRID:grid.5252.0) (ISNI:0000 0004 1936 973X) 
 Helmholtz Zentrum München, Institute of Stem Cell Research, Munich, Germany (GRID:grid.4567.0) (ISNI:0000 0004 0483 2525); Ruhr-University Bochum, Department of Dermatology, Bochum, Germany (GRID:grid.5570.7) (ISNI:0000 0004 0490 981X) 
Publication year
2022
Publication date
2022
Publisher
Nature Publishing Group
e-ISSN
20411723
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
2623500693
Copyright
© The Author(s) 2022. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.